Daniel Rea

Publications

  1. 1997
  2. Published

    Chemotherapy for epithelial ovarian cancer: An update

    Daniel Rea & Christopher Poole, 1 Jan 1997, In: Current Obstetrics and Gynaecology. 7, 1, p. 50-60 11 p.

    Research output: Contribution to journalReview articlepeer-review

  3. 1998
  4. Published

    Adjuvant tamoxifen: How long before we know how long?

    Daniel Rea, Christopher Poole & Richard Gray, 16 May 1998, In: BMJ. 316, 7143, 1 p.

    Research output: Contribution to journalArticlepeer-review

  5. Published

    From basic science to clinical practice: innovations in cancer therapy.

    Daniel Rea, 1 Dec 1998, In: Hospital medicine (London, England : 1998). 59, 12, p. 918-919 2 p.

    Research output: Contribution to journalEditorialpeer-review

  6. 2000
  7. Published

    Treatment of advanced disease

    Annie Young & Daniel Rea, 18 Nov 2000, In: BMJ. 321, 7271, p. 1278-1281 4 p.

    Research output: Contribution to journalArticlepeer-review

  8. 2001
  9. Published

    Dietary phytoestrogens influence susceptibility to breast cancer by inhibiting sulphotransferase enzymes?

    Chris Kirk, , , Philip Hughes, , Daniel Rea & Rosemary Waring, 1 Jan 2001, p. 82. 1 p.

    Research output: Contribution to conference (unpublished)Paper

  10. 2002
  11. Published
  12. Published

    Recent advances in chemotherapy for colorectal cancer

    Daniel Rea & David Kerr, 1 Jan 2002, In: Cancer Topics. 10, p. 16-19 4 p.

    Research output: Contribution to journalArticle

  13. 2003
  14. Published

    Chemotherapy for advanced colorectal cancer

    Daniel Rea, 1 Jan 2003, In: Colonews. 1, p. 3-6 4 p.

    Research output: Contribution to journalArticle

  15. Published
  16. Published

    Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer

    Daniel Rea, , , , , , , , , , , , & , 6 Oct 2003, In: British Journal of Cancer. 89, 7, p. 1155-1158 4 p.

    Research output: Contribution to journalArticle

  17. Published

    Coagulopathic complications in breast cancer

    Paul Stonelake, Daniel Rea & Gregory Lip, 15 Oct 2003, In: Cancer. 98, p. 1578-1586 9 p.

    Research output: Contribution to journalArticle

  18. 2004
  19. Published
  20. Published

    Adjuvant endocrine therapy for postmenopausal women with early stage breast cancer

    Daniel Rea, 1 Jan 2004, In: Therapy. 1, p. 1-14 14 p.

    Research output: Contribution to journalArticle

  21. Published

    Metastatic breast cancer response after exemestane withdrawal: A case report

    Daniel Rea, 1 Jan 2004, In: The Breast. 13, p. 66-68 3 p.

    Research output: Contribution to journalArticle

  22. Published

    Perspectives on the future of bisphosphonate use in breast cancer patients

    Daniel Rea, 1 Jan 2004, In: Seminars in Oncology. 31, p. 87-91 5 p.

    Research output: Contribution to journalArticle

  23. Published
  24. Published
  25. Published

    Endocrine therapy for early breast cancer

    Syed Hussain, , & Daniel Rea, 1 Oct 2004, In: Expert Review of Anticancer Therapy. 4, p. 877-888 12 p.

    Research output: Contribution to journalArticle

  26. Published
  27. 2005
  28. Published

    Role of chemotherapy in breast cancer

    Syed Hussain, Daniel Palmer, , , Christopher Poole & Daniel Rea, 1 Jan 2005, In: Expert Review of Anticancer Therapy. 5, p. 1095-1110 16 p.

    Research output: Contribution to journalArticle

  29. Published
  30. Published

    A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first line therapy for advanced colorectal cancer

    Daniel Rea, , , , , , , , , Neil Steven, , & , 25 May 2005, In: Annals of Oncology. 16, 7, p. 1123-1132 10 p.

    Research output: Contribution to journalArticle

  31. Published
  32. Published

    Antibacterial prophylaxis after chemotherapy for solid tumours and lymphomas

    Neil Steven, Lucinda Billingham, , , , , Daniel Rea, , , & , 8 Sep 2005, In: New England Journal of Medicine. 353, 10, p. 988-998 11 p.

    Research output: Contribution to journalArticle

  33. 2006
  34. Published
  35. Published

    Monitoring the introduction of new drugs: Herceptin and cardiotoxicity

    Daniel Rea & , 1 Jan 2006, In: Clinical Medicine. 6, p. 478-481 4 p.

    Research output: Contribution to journalArticle

  36. Published

    Oncology Emergencies

    Daniel Rea, Stephen Bain & Janesh Gupta, 1 Jan 2006, Core Clinical Cases.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  37. Published
  38. 2007
  39. Published

    Molecularly targeted therapeutics for breast cancer

    Syed Hussain, Daniel Palmer, & Daniel Rea, 1 Jan 2007, In: BioDrugs. 21, 4, p. 215-224 10 p.

    Research output: Contribution to journalArticle

  40. Published
  41. Published
  42. Published
  43. Published
  44. 2008
  45. Published
  46. Published
  47. Published
  48. Published

    Acute non-myelosuppressive complications of systemic anticancer therapy

    Daniel Rea, 1 Aug 2008, In: Clinical Medicine. 8, 4, p. 439-442 4 p.

    Research output: Contribution to journalEditorial

  49. 2009
  50. Published

    Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.

    Lucinda Billingham, , , , Daniel Rea, , , , & Keith Wheatley, 14 Feb 2009, In: Lancet. 373, 9663, p. 567-74 8 p.

    Research output: Contribution to journalArticlepeer-review

  51. Published

    Genomics and pharmacogenomics in the management of breast cancer

    Jennifer Pascoe, Daniel Palmer, , Daniel Rea & Syed Hussain, 1 Mar 2009, In: Current Pharmacogenomics. 6, 1, p. 45-55 11 p.

    Research output: Contribution to journalArticle

  52. Published

    Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

    Daniel Rea, , , , , , , , , , , , , , & , 1 Jun 2009, In: International Journal of Oncology. 34, 6, p. 1629-36 8 p.

    Research output: Contribution to journalArticlepeer-review

  53. Published

    Role of Tyrosine Kinase Inhibitors in Lung Cancer

    Daniel Palmer, Daniel Rea & Syed Hussain, 1 Jun 2009, In: Anti-Cancer Agents in Medicinal Chemistry. 9, 5, p. 569-575 7 p.

    Research output: Contribution to journalArticle

  54. Published
  55. 2010
  56. Published
  57. Published
  58. Published
  59. 2011
  60. Published

    Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

    Daniel Rea, , , , , , , , , , , , , , & , 1 Jan 2011, In: Lancet. 377, 9762, p. 321-331 11 p.

    Research output: Contribution to journalArticle

  61. Published
  62. Published
  63. Published
  64. 2012
  65. Published
  66. Published
  67. Published
  68. Published
  69. 2013
  70. Published

    Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: A Tamoxifen Exemestane Adjuvant Multinational Study Analysis

    Daniel Rea, , , , , , , & , 1 Feb 2013, In: Oncologist. 18, 1, p. 8-13 6 p.

    Research output: Contribution to journalArticlepeer-review

  71. Published

    Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA Trial

    Daniel Rea & 2 others, & , 1 Feb 2013, In: Clinical Oncology. 25, 2, p. 109-116 8 p.

    Research output: Contribution to journalArticlepeer-review

  72. Published
  73. Published
  74. Published

    Time to stop operating on breast cancer patients with pathological complete response?

    Daniel Rea, & , 1 Sep 2013, In: European Journal of Surgical Oncology. 39, 9, p. 924-930 7 p.

    Research output: Contribution to journalReview articlepeer-review

  75. Published

    Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

    Daniel Rea, 29 Oct 2013, In: British Journal of Cancer. 109, 9, p. 2453-2461 9 p.

    Research output: Contribution to journalArticlepeer-review

  76. Published

    Reply to K.I. Pritchard

    Daniel Rea, & , 10 Dec 2013, In: Journal of Clinical Oncology. 31, 35, p. 4477-4479 3 p.

    Research output: Contribution to journalArticlepeer-review

  77. 2014
  78. Published

    Breast screening saves lives: Now is the time to address overtreatment

    Daniel Rea & , 2014, In: Journal of Comparative Effectiveness Research. 3, 2, p. 111-113 3 p.

    Research output: Contribution to journalEditorialpeer-review

  79. Published

    Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

    Daniel Rea & , 20 Sep 2014, In: Journal of Clinical Oncology. 32, 27, p. 2951-2958

    Research output: Contribution to journalArticlepeer-review

  80. Published

    Low grade Ductal Carcinoma in situ (DCIS): how best to describe it?

    Daniel Rea, 1 Oct 2014, In: The Breast. 23, 5, p. 693-696 4 p.

    Research output: Contribution to journalArticlepeer-review

  81. Published

    Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

    Toon Brookes, Daniel Rea, , , , , & , 9 Dec 2014, In: British Journal of Cancer. 111, 12, p. 2242-2247 6 p.

    Research output: Contribution to journalArticlepeer-review

  82. 2015
  83. Published

    The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ

    Daniel Rea, 1 Jan 2015, In: Clinical Oncology. 27, 1, p. 6-8

    Research output: Contribution to journalEditorialpeer-review

  84. Published
  85. Published

    Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also

    Daniel Rea, , & , 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.

    Research output: Contribution to journalArticlepeer-review

  86. Published
  87. Published

    Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials

    Richard Gray & , 3 Oct 2015, In: The Lancet. 386, 10001, p. 1341-1352 12 p.

    Research output: Contribution to journalArticlepeer-review

  88. Published

    Addressing overtreatment of screen detected DCIS; the LORIS trial

    Toon Brookes, Tracy Roberts, Sarah Pirrie, Lucinda Billingham & 2 others, Sarah Bowden & Daniel Rea, Nov 2015, In: European Journal of Cancer. 51, 16, p. 2296-2303 8 p.

    Research output: Contribution to journalArticlepeer-review

  89. 2016
  90. Published
  91. Published

    Cardiac safety of simultaneous anti-HER2 and anthracycline therapy

    Mariam Jafri & Daniel Rea, Feb 2016, In: Breast Cancer Management. 5, 1, p. 21-29

    Research output: Contribution to journalArticlepeer-review

  92. Published
  93. Published
  94. Published

    Neoadjuvant chemotherapy in triple negative breast cancer: An observational study

    Daniel Rea, 2 May 2016, In: Oncology Research. 23, 6, p. 291-302 12 p.

    Research output: Contribution to journalArticlepeer-review

  95. Published
  96. Published

    Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right

    Daniel Rea, , , , , , & , 1 Jul 2016, In: European Journal of Surgical Oncology. 42, 7, p. 994-998 5 p.

    Research output: Contribution to journalArticlepeer-review

  97. Published
  98. Published

    Comparison of quadrant-specific breast cancer incidence trends in the United States and England between 1975 and 2013

    Daniel Rea, & , 1 Oct 2016, In: Cancer Epidemiology. 44, p. 186-194 9 p.

    Research output: Contribution to journalArticlepeer-review

  99. 2017
  100. Published

    Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

    Toon Brookes, , , , , , , Daniel Rea, & , 2017, In: Breast Cancer. 3, p. 3

    Research output: Contribution to journalArticlepeer-review

  101. Published
  102. E-pub ahead of print

    Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial

    Daniel Rea & 1 others, , 26 May 2017, (E-pub ahead of print) In: Modern Pathology. 30, p. 1069-1077

    Research output: Contribution to journalArticlepeer-review

  103. Published
  104. Published

    The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?

    Daniel Rea, , , , , , , , , , , , , & , 1 Jun 2017, In: The Breast. 33, p. 191-199 9 p.

    Research output: Contribution to journalArticlepeer-review

  105. Published
  106. E-pub ahead of print

    Adjuvant tamoxifen and exemestane in postmenopausal early breast cancer: ten-year analysis of the randomised phase III TEAM trial

    Daniel Rea, , , , , & , 18 Jul 2017, (E-pub ahead of print) In: The Lancet Oncology.

    Research output: Contribution to journalArticlepeer-review

  107. E-pub ahead of print
  108. Published

    Value of information analysis of multiparameter tests for chemotherapy in early breast cancer: the OPTIMA prelim trial

    Daniel Rea, , , , , & , Dec 2017, In: Value in Health. 20, 10, p. 1311-1318 8 p.

    Research output: Contribution to journalArticlepeer-review

  109. Published
  110. 2018
  111. Published
  112. Published

    Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

    & 12 others, , , , , , , Daniel Rea, , , , & , 1 Apr 2018, In: Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.

    Research output: Contribution to journalArticlepeer-review

  113. Published
  114. Published
  115. Published
  116. Published

    Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial

    Daniel Rea, , , , , & , 1 Aug 2018, In: European Journal of Cancer . 99, p. 1-8 8 p.

    Research output: Contribution to journalArticlepeer-review

  117. Published

    Pathway-based subnetworks enable cross-disease biomarker discovery

    Daniel Rea & 5 others, , , , & , 12 Nov 2018, In: Nature Communications. 9, 1, 4746.

    Research output: Contribution to journalArticlepeer-review

  118. Published
  119. 2019
  120. Published
  121. Published

    The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

    & 35 others, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & Daniel Rea, 1 Feb 2019, In: Journal of Clinical Epidemiology. 106, p. 108-120 13 p.

    Research output: Contribution to journalArticlepeer-review

  122. Published
Previous 1 2 Next